NCHS Data Brief ■ No. 314 ■ July 2018

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

National Center for Health Statistics

Trends in Liver Cancer Mortality Among Adults Aged 25 and 

Over in the United States, 2000–2016

Jiaquan Xu, M.D.

Key findings

Data from the National 

Vital Statistics System, 

Mortality

● Age-adjusted death rates for

liver cancer increased 43%,

from 10.5 per 100,000 U.S.

standard population to 15.0 for

men and 40%, from 4.5 to 6.3

for women, between 2000 and

2016.

● During 2000–2016, liver

cancer death rates decreased

22% for non-Hispanic Asian

or Pacific Islander (API)

adults, but increased 48% for

non-Hispanic white, 43% for

non-Hispanic black, and 27%

for Hispanic adults.

● Trends in liver cancer death

rates varied by age group, but 

increasing trends from 2000 

through 2016 were observed 

for adults aged 65–74 and 75 

and over.

● In 2016, among the 50 states

and the District of Columbia 

(D.C.), D.C. had the highest 

death rate while Vermont had 

the lowest.

Liver cancer (including intrahepatic bile duct cancer) was the ninth leading 

cause of cancer death in 2000 and rose to sixth in 2016 (1). Although death 

rates for all cancer combined have declined since 1990, a recent report 

documented an increasing trend in liver cancer death rates during 1990–2014 

(2,3). In this report, trends in liver cancer death rates are examined by sex, race 

and Hispanic origin, and age group from 2000 through 2016 for adults aged 25 

and over. Death rates in 2016 by state and the District of Columbia (D.C.) are 

also presented. 

Keywords: sex • intrahepatic bile duct • race and ethnicity • National Vital 

Statistics System

Age-adjusted liver cancer death rates increased steadily 

from 2000 through 2016 for both men and women aged 25 

and over.

Figure 1. Age-adjusted death rates for liver cancer among adults aged 25 and over, by sex:

United States, 2000–2016

1

Significant increasing trend from 2000 to 2016 (p < 0.05). 2

Significantly higher than women throughout the period (p < 0.05).

NOTES: Liver cancer deaths are identified with International Classification of Diseases, 10th Revision, using underlying 

cause-of-death code C22. Access data table for Figure 1 at: https://www.cdc.gov/nchs/data/databriefs/db314_table.pdf#1.

SOURCE: NCHS, National Vital Statistics System, Mortality. 
● Liver cancer death rates for adults aged 25 and over increased 43% from 7.2 per 100,000

U.S. standard population in 2000 to 10.3 in 2016 (Figure 1).

● Liver cancer death rates increased 43% from 10.5 in 2000 to 15.0 in 2016 for men and 40%

from 4.5 to 6.3 for women.

● The death rate for men was between 2.0–2.5 times the rate for women throughout the

period.

Age-adjusted death rates for liver cancer increased during 2000–2016 for 

non-Hispanic white, non-Hispanic black, and Hispanic adults but decreased 

for non-Hispanic Asian or Pacific Islander adults.

● During 2000–2016, the age-adjusted death rate for liver cancer increased 48% (6.1 per

100,000 U.S. standard population to 9.0) for non-Hispanic white adults and 43% (9.5 to

13.6) for non-Hispanic black adults (Figure 2).

● While non-Hispanic Asian or Pacific Islander (API) adults had the highest liver cancer

death rates during 2000–2014 among the four race and Hispanic-origin groups, this group

experienced the only decrease (22%), from 17.5 in 2000 to 13.6 in 2016.

● The liver cancer death rate increased 27% from 11.5 in 2000 to 14.6 in 2016 for Hispanic

adults, surpassing the rate for non-Hispanic API adults in 2016.

 

Figure 2. Age-adjusted death rates for liver cancer among adults aged 25 and over, by race and ethnicity: United States, 

2000–2016

1

Significant decreasing trend for non-Hispanic Asian or Pacific Islander adults from 2000 to 2016 (p < 0.05). 2

Significantly higher compared with non-Hispanic white adults throughout the period (p < 0.05). 3

Significant increasing trend from 2000 to 2016 (p < 0.05).

NOTES: Liver cancer deaths are identified with International Classification of Diseases, 10th Revision, using underlying cause-of-death code C22. Access data 

table for Figure 2 at: https://www.cdc.gov/nchs/data/databriefs/db314_table.pdf#2.

SOURCE: NCHS, National Vital Statistics System, Mortality.

■ 2 ■
NCHS Data Brief ■ No. 314 ■ July 20l8

■ 3  ■

● Non-Hispanic white adults had the lowest death rate among the four racial and ethnic groups

throughout the period.

Death rates for liver cancer increased from 2000 through 2016 for age 

groups 65–74 and 75 and over.

● For adults aged 25–44, the rate remained essentially unchanged during 2000–2016

(Figure 3).

● For adults aged 45–54, the rate increased 31% from 2000 to 2005, remained stable from

2005 to 2012, and then decreased 20%, from 5.5 per 100,000 population in 2012 to 4.4 in

2016.

● For adults aged 55–64, the rate increased 109% from 9.3 in 2000 to 19.4 in 2013, but

remained stable through 2016.

● For adults aged 65–74, the rate increased 7%, from 18.7 in 2000 to 20.0 in 2008, and 37%

from 20.0 in 2008 to 27.3 in 2016. The rate increased 35% (29.8 in 2000 to 40.2 in 2016) for

adults aged 75 and over.

● The liver cancer death rate was the highest for adults aged 75 and over, followed by age

groups 65–74, 55–64, 45–54, and 25–44.

 

Figure 3. Death rates for liver cancer among adults aged 25 and over, by selected age groups: United States, 2000–2016

1

Significant increasing trend from 2000 to 2016 (p < 0.05). 2

Significant differences across all age groups throughout the period (p < 0.05). 3

Significant increasing trend from 2000 to 2013 (p < 0.05), and stable trend from 2013 to 2016. 4

Significant increasing trend from 2000 to 2005 (p < 0.05), stable trend from 2005 to 2012, and decreasing trend from 2012 to 2016 (p < 0.05).

NOTES: Rates are plotted on a logarithmic scale. Liver cancer deaths are identified with International Classification of Diseases, 10th Revision, using underlying 

cause-of-death code C22. Access data table for Figure 3 at https://www.cdc.gov/nchs/data/databriefs/db314_table.pdf#3.

SOURCE: NCHS, National Vital Statistics System, Mortality.
■  4  ■

In 2016, the District of Columbia had the highest age-adjusted liver cancer 

death rate and Vermont had the lowest rate.

● In 2016, age-adjusted death rates for liver cancer among adults were highest in D.C. (16.8

per 100,000 U.S. standard population), Louisiana (13.8), Hawaii (12.7), and Mississippi and

New Mexico (12.4 each) (Figure 4).

● The five states with the lowest age-adjusted liver cancer death rates were Vermont (6.0),

Maine (7.4), Montana (7.7), and Utah and Nebraska (7.8 each).

Figure 4. Age-adjusted death rates for liver cancer among adults aged 25 and over, by state: United States, 2016

NOTES: Liver cancer deaths are identified with International Classification of Diseases, 10th Revision, using underlying cause-of-death code C22. Access data 

table for Figure 4 at https://www.cdc.gov/nchs/data/databriefs/db314_table.pdf#4.

SOURCE: NCHS, National Vital Statistics System, Mortality.

 
NCHS Data Brief ■ No. 314 ■ July 20l8

■ 5  ■

Summary

This report provides the most recent trends in liver cancer mortality by sex, race and Hispanic 

origin, and age group for adults aged 25 and over. From 2000 through 2016, death rates increased 

significantly for both men and women, with the death rate for men between two and two and a 

half times the rate for women. Liver cancer death rates increased for non-Hispanic white, nonHispanic black, and Hispanic adults, but declined for non-Hispanic API adults. The rate for 

non-Hispanic white adults aged 25 and over was the lowest of the four race and Hispanic-origin 

groups from 2000 through 2016, while the rate for non-Hispanic API adults was the highest from 

2000 through 2014. The death rate for Hispanic adults surpassed the rate for non-Hispanic API 

adults in 2016, thus becoming the highest among the four race and ethnicity groups. From 2000 

to 2016, death rates for liver cancer increased significantly for age groups 65–74 and 75 and over. 

The rate for adults aged 45–54 initially increased, but then decreased significantly since 2012. 

Liver cancer death rates in 2016 varied by jurisdiction, with the lowest death rate in Vermont and 

the highest in D.C.

Definitions

Cause-of-death classification: Cause of death is determined based on medical information 

entered on death certificates filed in the United States. This information is classified and coded 

in accordance with the International Statistical Classification of Diseases and Related Health 

Problems, 10th Revision (ICD–10) (4).

Underlying causes of death: Defined by the World Health Organization as “the disease or injury 

which initiate the train of events leading directly to death, or the circumstances of the accident 

or violence which produce the fatal injury” (4). In the case of liver cancer deaths, the underlying 

cause of death is coded to C22 according to ICD–10.
■ 6  ■

NCHS Data Brief ■ No. 314 ■ July 2018

Data source and methods

All data in the report are from the 2000 to 2016 mortality files from the National Vital Statistics 

System. The direct standardization method was used to calculate age-adjusted death rates, using 

the 2000 U.S. standard population aged 25 and over and age groups with 10-year intervals (5). 

More than 99% of all deaths with liver cancer reported on the death certificate were to adults 

25 years of age and over and, therefore, only decedents aged 25 and over were included in this 

analysis. Race and Hispanic origin are reported separately on the death certificate. Persons of 

Hispanic origin may be of any race. A recent report has shown that, in the 1999–2011 period, 

deaths for the non-Hispanic API and Hispanic populations were underreported by 3% for all 

ages in each group (6). It was presumed that the degree of underreporting of deaths observed for 

the non-Hispanic API and Hispanic populations in 1999–2011 data also applied to the data for 

years 2012–2016. Trends in death rates were evaluated using Joinpoint Regression Program (7). 

A maximum of three joinpoints were allowed during the 2000–2016 period, which is the default 

setting. The differences between death rates were evaluated using a two-tailed z test at the 0.05 

level.

About the author

Jiaquan Xu is with the National Center for Health Statistics, Division of Vital Statistics, 

Mortality Statistics Branch. The author gratefully acknowledges the assistance of Sally C. Curtin, 

who provided the content review.
NCHS Data Brief ■ No. 314 ■ July 20l8

■ 7  ■

References

1. Centers for Disease Control and Prevention. Wide-ranging online data for epidemiologic

research (WONDER). Underlying cause of death output based on the Detailed Mortality File.

Available from: https://wonder.cdc.gov/.

2. Xu JQ, Murphy SL, Kochanek KD, Bastian BA, Arias E. Deaths: Final data for 2016.

National Vital Statistics Reports; vol 67 no 5. Hyattsville, MD: National Center for Health

Statistics. 2018.

3. Islami F, Miller KD, Siegel RL, Fedewa SA, Ward EM, Jemal A. Disparities in liver cancer

occurrence in the United States by race/ethnicity and state. CA Cancer J Clin 67(4). 2017.

Available from: https://onlinelibrary.wiley.com/doi/10.3322/caac.21402/epdf.

4. World Health Organization. International statistical classification of diseases and related

health problems, 10th revision (ICD–10). 2008 ed. Geneva, Switzerland. 2009.

5. National Center for Health Statistics. National Vital Statistics System. U.S. census

populations with bridged race categories. Available from: https://www.cdc.gov/nchs/nvss/

bridged_race/data_documentation.htm.

6. Arias E, Heron M, Hakes JK. The validity of race and Hispanic-origin reporting on death

certificates in the United States: An update. Vital Health Stat 2(172). Hyattsville, MD: National

Center for Health Statistics. 2016. Available from: https://www.cdc.gov/nchs/data/series/sr_02/

sr02_172.pdf.

7. National Cancer Institute. Joinpoint Regression Program (Version 4.4.0.0) [computer

software]. 2017. 
NCHS Data Brief ■ No. 314 ■ July 2018

Suggested citation

Xu JQ. Trends in liver cancer mortality 

among adults aged 25 and over in the United 

States, 2000–2016. NCHS Data Brief, no 

314. Hyattsville, MD: National Center for

Health Statistics. 2018.

Copyright information

All material appearing in this report is in 

the public domain and may be reproduced 

or copied without permission; citation as to 

source, however, is appreciated.

National Center for Health 

Statistics

Charles J. Rothwell, M.S., M.B.A., Director

Jennifer H. Madans, Ph.D., Associate 

Director for Science

Division of Vital Statistics

Delton Atkinson, M.P.H., M.P.H., P.M.P., 

Director

Hanyu Ni, Ph.D., M.P.H., Associate Director 

for Science

For e-mail updates on NCHS publication 

releases, subscribe online at: 

https://www.cdc.gov/nchs/govdelivery.htm.

For questions or general information

about NCHS:

Tel: 1–800–CDC–INFO (1–800–232–4636)

TTY: 1–888–232–6348

Internet: https://www.cdc.gov/nchs

Online request form: https://www.cdc.gov/info

ISSN 1941–4927 Print ed.

ISSN 1941–4935 Online ed.

DHHS Publication No. 2018–1209

CS294257

U.S. DEPARTMENT OF

HEALTH & HUMAN SERVICES

Centers for Disease Control and Prevention

National Center for Health Statistics

3311 Toledo Road, Room 4551, MS P08

Hyattsville, MD 20782–2064

OFFICIAL BUSINESS 

PENALTY FOR PRIVATE USE, $300

For more NCHS Data Briefs, visit:

https://www.cdc.gov/nchs/products/databriefs.htm.

FIRST CLASS MAIL 

POSTAGE & FEES PAID 

CDC/NCHS

PERMIT NO. G-284